{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:19:11Z","timestamp":1774009151901,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.atherosclerosis.2025.120621","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:18:09Z","timestamp":1770229089000},"page":"120621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The hidden burden of kidney damage in chylomicronemia syndromes"],"prefix":"10.1016","volume":"413","author":[{"given":"Laura","family":"D'Erasmo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-2451","authenticated-orcid":false,"given":"Daniele","family":"Tramontano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Di Costanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Bini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Commodari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Arizaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Pecce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Cerbelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilenia","family":"Minicocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Larouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.atherosclerosis.2025.120621_bib1","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120621_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/metabo13050621","article-title":"Severe hypertriglyceridaemia and chylomicronaemia Syndrome-Causes, clinical presentation, and therapeutic options","volume":"13","author":"Bashir","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2025.03.012","article-title":"Recognition and management of persistent chylomicronemia: a joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","author":"Saadatagah","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120621_bib4","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/ATVBAHA.119.313401","article-title":"Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes","volume":"39","author":"D'Erasmo","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120621_bib5","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1210\/js.2019-00214","article-title":"Differentiating familial chylomicronemia syndrome from multifactorial severe hypertriglyceridemia by clinical profiles","volume":"3","author":"O'Dea","year":"2019","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120621_bib6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120621_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-020-00885-1","article-title":"Familial Chylomicronemia Syndrome (FCS): recent data on diagnosis and treatment","volume":"22","author":"Gallo","year":"2020","journal-title":"Curr Atheroscler Rep"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120621_bib8","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00375.2015","article-title":"Systemic and renal lipids in kidney disease development and progression","volume":"310","author":"Wahl","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejim.2023.02.019","article-title":"Hypertriglyceridemia is associated with decline of estimated glomerular filtration rate and risk of end-stage kidney disease in a real-word Italian cohort: evidence from the TG-RENAL Study","volume":"111","author":"Pontremoli","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120621_bib10","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1080\/0886022X.2019.1655451","article-title":"Plasma triglyceride levels and central obesity predict the development of kidney injury in Chinese community older adults","volume":"41","author":"Cao","year":"2019","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120621_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000522388","article-title":"Association of Serum triglycerides and renal outcomes among 1.6 million US veterans","volume":"146","author":"Soohoo","year":"2022","journal-title":"Nephron"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2025.120621_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000529414","article-title":"Triglycerides and renal outcomes according to Albuminuria and in consideration of other metabolic Syndrome components in diabetic US veterans","volume":"54","author":"Rizk","year":"2023","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120621_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/0886022X.2020.1853569","article-title":"Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults","volume":"43","author":"Huang","year":"2021","journal-title":"Ren Fail"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120621_bib14","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.3390\/ijerph110807622","article-title":"Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population","volume":"11","author":"Zhang","year":"2014","journal-title":"Int J Environ Res Publ Health"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2025.120621_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125512","article-title":"Hypertriglyceridemia is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter Study","volume":"10","author":"Penno","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119146","article-title":"The vicious circle of chronic kidney disease and hypertriglyceridemia: what is first, the hen or the egg?","volume":"403","author":"Tramontano","year":"2025","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120621_bib17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurjpc\/zwae036","article-title":"Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry","volume":"31","author":"D'Erasmo","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2017.07.001","article-title":"Familial hypercholesterolemia: the Italian Atherosclerosis Society Network (LIPIGEN)","volume":"29","author":"Averna","year":"2017","journal-title":"Atherosclerosis Suppl"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.125.323340","article-title":"Contemporary management of familial and multifactorial chylomicronemia syndromes in Italy: insights from the National Lipigen registry","author":"D'Erasmo","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2016.12.018","article-title":"Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage","volume":"257","author":"Di Costanzo","year":"2017","journal-title":"Atherosclerosis"},{"issue":"4S","key":"10.1016\/j.atherosclerosis.2025.120621_bib21","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120621_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001481","article-title":"Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study","volume":"8","author":"Penno","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120621_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2025.120621_bib24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \"FCS score\"","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120621_bib26","article-title":"An updated review and Meta analysis of Lipoprotein Glomerulopathy","volume":"9","author":"Li","year":"2022","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120621_bib27","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.ekir.2023.08.027","article-title":"Loss-of-Function homozygous variant in LPL causes type I hyperlipoproteinemia and renal lipidosis","volume":"8","author":"Wu","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120621_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/ajkd.2002.31388","article-title":"Microalbuminuria in the US population: third national Health and Nutrition Examination Survey","volume":"39","author":"Jones","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120621_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10157-007-0010-9","article-title":"Chronic kidney disease perspectives in Japan and the importance of urinalysis screening","volume":"12","author":"Yamagata","year":"2008","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120621_bib30a","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/011969ee-3f4b-4260-8d95-1b9a4ca39008","article-title":"The prevalence of chronic kidney disease in a primary care setting: a Swiss cross-sectional study","volume":"8","author":"Tomonaga","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2025.120621_bib30b","volume":"8","author":"Ambuehl","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2025.120621_bib31","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1001\/archinte.165.20.2420","article-title":"A prospective study of plasma lipid levels and hypertension in women","volume":"165","author":"Sesso","year":"2005","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120621_bib32","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/HYPERTENSIONAHA.122.19510","article-title":"Potential mediators of causal associations of circulating triglycerides with blood pressure: evidence from genetic and observational data","volume":"79","author":"Liu","year":"2022","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120621_bib33","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2174\/1871530323666230619104853","article-title":"An independent risk factor for new-onset hypertension: a perspective","volume":"23","author":"Triglyceride","year":"2023","journal-title":"Endocr, Metab Immune Disord: Drug Targets"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025015199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025015199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:20:54Z","timestamp":1774002054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025015199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S0021915025015199"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120621","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hidden burden of kidney damage in chylomicronemia syndromes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120621"}}